DaVita stock holds firm as earnings and cash flow support dialysis strategy
DaVita Inc. (ISIN US23918K1088) demonstrates a stable business model focused on dialysis services, reporting $11.6 billion in annual revenue and improved profitability. The company's financial health is supported by strong operating cash flow of $1.8 billion, which is used for debt reduction and significant …